Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thioglycolic acid (TGA), also known as mercaptoacetic acid (MAA), is an organic compound characterized by the presence of both a thiol (mercaptan) and a carboxylic acid functional group. It is a clear, colorless liquid with a strong, unpleasant odor. TGA is widely utilized across various industries, including cosmetics for hair treatments, depilatories, and permanent wave solutions, as well as in the oil and gas sector for corrosion inhibition and metal complexing. It also finds applications in cleaning formulations, leather processing, and chemical synthesis. In cosmetic and dermatological applications, its primary mechanism involves acting as a reducing agent to break disulfide bonds in keratin proteins, facilitating hair reshaping, depilation, or exfoliation as a keratolytic agent in chemical peels. Additionally, it functions as a powerful complexing and chelating agent with various metal ions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Thioglycolic acid.